Mechanisms of gelsolin-dependent and -independent EGF-stimulated cell motility in a human lung epithelial cell line
- 1 July 2005
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 307 (1) , 153-163
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 43 references indexed in Scilit:
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung CancerNew England Journal of Medicine, 2002
- Downregulation of Gelsolin Correlates with the Progression to Breast CarcinomaBreast Cancer Research and Treatment, 2001
- Rho GTPases: Signaling, Migration, and InvasionExperimental Cell Research, 2000
- Downregulated gelsolin expression in hyperplastic and neoplastic lesions of the prostateThe Prostate, 1999
- Cell motility as a prognostic factor in Stage I nonsmall cell lung carcinomaCancer, 1999
- Gelsolin is a downstream effector of rac for fibroblast motilityThe EMBO Journal, 1998
- A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility.Journal of Cell Biology, 1996
- Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolinCell, 1995
- Enhanced Motility in NIH 3T3 Fibroblasts That Overexpress GelsolinScience, 1991